相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。CRISPR/Cas9-based genome editing in the era of CAR T cell immunotherapy
January Salas-Mckee et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2019)
Therapeutic challenges and current immunomodulatory strategies in targeting the immunosuppressive pancreatic tumor microenvironment
Chin-King Looi et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Tumor neoantigens: from basic research to clinical applications
Tao Jiang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Neoantigen vaccine: an emerging tumor immunotherapy
Miao Peng et al.
MOLECULAR CANCER (2019)
Mutation-Derived Neoantigens for Cancer Immunotherapy
John C. Castle et al.
FRONTIERS IN IMMUNOLOGY (2019)
Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients
V. Gopalakrishnan et al.
SCIENCE (2018)
The Immune Revolution: A Case for Priming, Not Checkpoint
Robert H. Vonderheide
CANCER CELL (2018)
The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy
Vancheswaran Gopalakrishnan et al.
CANCER CELL (2018)
An Update on Immunotherapy for Solid Tumors: A Review
Toan Pham et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
CRISPR/Cas9 and CAR-T cell, collaboration of two revolutionary technologies in cancer immunotherapy, an instruction for successful cancer treatment
Hasan Mollanoori et al.
HUMAN IMMUNOLOGY (2018)
Natural Killer Cells: Development, Maturation, and Clinical Utilization
Alex M. Abel et al.
FRONTIERS IN IMMUNOLOGY (2018)
Hyperprogressive Disease in Patients With Advanced Non-Small Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors or With Single-Agent Chemotherapy
Roberto Ferrara et al.
JAMA ONCOLOGY (2018)
Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis
Yinghong Wang et al.
NATURE MEDICINE (2018)
Role of the immunosuppressive microenvironment in immunotherapy
Garth W. Tormoen et al.
ADVANCES IN RADIATION ONCOLOGY (2018)
Direct reprogramming of fibroblasts into antigen-presenting dendritic cells
Fabio F. Rosa et al.
SCIENCE IMMUNOLOGY (2018)
Personalized tumor vaccines keep cancer in check
Jocelyn Kaiser
SCIENCE (2017)
Cancer immunotherapy: Historical Perspective of a Clinical Revolution and emerging Preclinical Animal Models
William K. Decker et al.
FRONTIERS IN IMMUNOLOGY (2017)
Targeting Legumain As a Novel Therapeutic Strategy in Cancers
Chun-Wai Mai et al.
CURRENT DRUG TARGETS (2017)
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
Padmanee Sharma et al.
CELL (2017)
Cytochrome P450 2W1 (CYP2W1) in Colorectal Cancers
Felicia Fei-Lei Chung et al.
CURRENT CANCER DRUG TARGETS (2016)
The urgent need to recover MHC class I in cancers for effective immunotherapy
Federico Garrido et al.
CURRENT OPINION IN IMMUNOLOGY (2016)
Cancer immunotherapy targeting neoantigens
Yong-Chen Lu et al.
SEMINARS IN IMMUNOLOGY (2016)
Restoring Lost Anti-HER-2 Th1 Immunity in Breast Cancer: A Crucial Role for Th1 Cytokines in Therapy and Prevention
Nadia F. Nocera et al.
FRONTIERS IN PHARMACOLOGY (2016)
Going viral: a review of replication-selective oncolytic adenoviruses
Christopher Larson et al.
ONCOTARGET (2015)
4-1BB (CD137), an inducible costimulatory receptor, as a specific target for cancer therapy
Dass S. Vinay et al.
BMB REPORTS (2014)
IL-2: The First Effective Immunotherapy for Human Cancer
Steven A. Rosenberg
JOURNAL OF IMMUNOLOGY (2014)
Inhibition of PD-L1 by MPDL3280A and clinical activity in pts with metastatic urothelial bladder cancer (UBC).
Thomas Powles et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Rituximab causes a polarization of B cells that augments its therapeutic function in NK-cell-mediated antibody-dependent cellular cytotoxicity
Dominika Rudnicka et al.
BLOOD (2013)
CSF1R Signaling Blockade Stanches Tumor-Infiltrating Myeloid Cells and Improves the Efficacy of Radiotherapy in Prostate Cancer
Jingying Xu et al.
CANCER RESEARCH (2013)
Targeting immunosuppression for cancer therapy
Cristina Ghirelli et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Immunosuppressants in cancer prevention and therapy
Mikhail V. Blagosklonny
ONCOIMMUNOLOGY (2013)
HER-2 pulsed dendritic cell vaccine can eliminate HER-2 expression and impact ductal carcinoma in situ
Anupama Sharma et al.
CANCER (2012)
Immunotherapy of Cancer with 4-1BB
Dass S. Vinay et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Tolerance to apoptotic cells is regulated by indoleamine 2,3-dioxygenase
Buvana Ravishankar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
Robert D. Schreiber et al.
SCIENCE (2011)
Hard and soft lesions underlying the HLA Class I alterations in cancer cells: implications for immunotherapy
Federico Garrido et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer.
Philip W. Kantoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Bioimmunoadjuvants for the treatment of neoplastic and infectious disease: Coley's legacy revisited
William K. Decker et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2009)
Whole-cell cancer vaccination: from autologous to allogeneic tumor- and dendritic cell-based vaccines
Tanja D. de Gruijl et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Phase I/II study of vaccination with electrofused allogeneic dendritic Cells/Autologous tumor-derived cells in patients with stage IV renal cell carcinoma
David E. Avigan et al.
JOURNAL OF IMMUNOTHERAPY (2007)
Inhibitory effect of tumor cell-derived lactic acid on human T cells
Karin Fischer et al.
BLOOD (2007)
A brief history of vaccines and vaccination
M. Lombard et al.
REVUE SCIENTIFIQUE ET TECHNIQUE-OFFICE INTERNATIONAL DES EPIZOOTIES (2007)
Immunosuppressive networks in the tumour environment and their therapeutic relevance
WP Zou
NATURE REVIEWS CANCER (2005)
Tumor-associated macrophages: The double-edged sword in cancer progression
JJW Chen et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Paul Ehrlich - in search of the magic bullet
F Winau et al.
MICROBES AND INFECTION (2004)
The three Es of cancer immunoediting
GP Dunn et al.
ANNUAL REVIEW OF IMMUNOLOGY (2004)
Cancer immunoediting: from immunosurveillance to tumor escape
GP Dunn et al.
NATURE IMMUNOLOGY (2002)
CD4+ and CD8+ anergic T cells induced by interleukin-10-treated human dendritic cells display antigen-specific suppressor activity
K Steinbrink et al.
BLOOD (2002)
IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
V Shankaran et al.
NATURE (2001)
分享论文
